Poly(I:C) is an effective adjuvant for antibody and multi-functional CD4+ T cell responses to Plasmodium falciparum circumsporozoite protein (CSP) and αDEC-CSP in non human primates. - Wikidata - awgldk - TriplyDB

Poly(I:C) is an effective adjuvant for antibody and multi-functional CD4+ T cell responses to Plasmodium falciparum circumsporozoite protein (CSP) and αDEC-CSP in non human primates.

Poly(I:C) is an effective adjuvant for antibody and multi-functional CD4+ T cell responses to Plasmodium falciparum circumsporozoite protein (CSP) and αDEC-CSP in non human primates.

http://www.wikidata.org/entity/Q34416103

about

Adjuvants: Classification, Modus Operandi, and Licensing Dendritic Cells and Their Multiple Roles during Malaria Infection Delivering HIV Gagp24 to DCIR Induces Strong Antibody Responses In Vivo PolyICLC Exerts Pro- and Anti-HIV Effects on the DC-T Cell Milieu In Vitro and In Vivo Immunogenicity of DNA vaccines encoding simian immunodeficiency virus antigen targeted to dendritic cells in rhesus macaques Vaccine design for CD8 T lymphocyte responses Resiquimod and polyinosinic-polycytidylic acid formulation with aluminum hydroxide as an adjuvant for foot-and-mouth disease vaccine.Toll-like receptor agonist augments virus-like particle-mediated protection from Ebola virus with transient immune activation.Yeast lysates carrying the nucleoprotein from measles virus vaccine as a novel subunit vaccine platform to deliver Plasmodium circumsporozoite antigen.Coadministration of polyinosinic:polycytidylic acid and immunostimulatory complexes modifies antigen processing in dendritic cell subsets and enhances HIV gag-specific T cell immunity.Human XCR1+ dendritic cells derived in vitro from CD34+ progenitors closely resemble blood dendritic cells, including their adjuvant responsiveness, contrary to monocyte-derived dendritic cells.Sweeten PAMPs: Role of Sugar Complexed PAMPs in Innate Immunity and Vaccine Biology.Targeting the non-structural protein 1 from dengue virus to a dendritic cell population confers protective immunity to lethal virus challenge Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates.Using Poly I:C as an adjuvant does not induce or exacerbate models of systemic lupus erythematosus.Nanoparticulate STING agonists are potent lymph node-targeted vaccine adjuvants.Effects of adjuvants on IgG subclasses elicited by virus-like particles.Immunization route dictates cross-priming efficiency and impacts the optimal timing of adjuvant delivery Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques.Filarial infection suppresses malaria-specific multifunctional Th1 and Th17 responses in malaria and filarial coinfections Full-length Plasmodium falciparum circumsporozoite protein administered with long-chain poly(I·C) or the Toll-like receptor 4 agonist glucopyranosyl lipid adjuvant-stable emulsion elicits potent antibody and CD4+ T cell immunity and protection in mi Polyinosinic-polycytidylic acid is the most effective TLR adjuvant for SIV Gag protein-induced T cell responses in nonhuman primates.Targeted antigen delivery to DEC-205⁺ dendritic cells for tolerogenic vaccination Chemical cross-linking of HIV-1 Env for direct TLR7/8 ligand conjugation compromises recognition of conserved antigenic determinants Skin scarification with Plasmodium falciparum peptide vaccine using synthetic TLR agonists as adjuvants elicits malaria sporozoite neutralizing immunity The presence of T cell epitopes is important for induction of antibody responses against antigens directed to DEC205+ dendritic cells.Liposome-antigen-nucleic acid complexes protect mice from lethal challenge with western and eastern equine encephalitis viruses.Dendritic Cell Targeting Effectively Boosts T Cell Responses Elicited by an HIV Multiepitope DNA Vaccine.Rhesus macaque and mouse models for down-selecting circumsporozoite protein based malaria vaccines differ significantly in immunogenicity and functional outcomes Toll-like receptor modulators: a patent review (2006-2010).Myeloid dendritic cells in HIV-1 infection.Plasmodium falciparum malaria vaccines: current status, pitfalls and future directions.Synthetic adjuvants for vaccine formulations: phytol derivatives.Vaccine design: emerging concepts and renewed optimism.Dendritic cell-targeted vaccines.Vaccine adjuvant uses of poly-IC and derivatives.Defective NF-κB signaling in metastatic head and neck cancer cells leads to enhanced apoptosis by double-stranded RNA.Highly immunostimulatory RNA derived from a Sendai virus defective viral genome Total Leishmania antigens with Poly(I:C) induce Th1 protective response.Improving the efficacy of a prophylactic vaccine formulation against lymphatic filariasis.

P2860

Q26747586-02C0B795-742F-4611-80C5-DDB942DFB535 Q26750593-521F565E-4A2C-4A65-A0CF-9D42241CBBE5 Q27300713-96614AC4-8952-4491-A0E2-4C8A71ADBC88 Q27324710-5FD638BA-4595-4071-9B1B-39BCB3B77FFA Q28728563-95686E03-A158-43A3-861A-53AFE25652AA Q30411492-8B28BA57-1F70-4515-8D13-98F36C3B3FA4 Q31147070-08186723-E83B-4A2B-9307-257A583BB15C Q31152190-6594BBDD-BCBC-4377-AE36-1B35236F0D12 Q32175658-6AF6E1E1-CD2F-4AC8-AC8D-2368EC07114A Q33909362-64987332-630A-4651-81AB-18CD54032D52 Q33998442-5A15D0AF-F6A8-479A-B561-1EA75EB531F8 Q34370741-D99569EE-E786-4761-9BD8-6895ADDFB4F6 Q34855420-DA921CF0-61A4-4A08-938B-DD4F5B1DBBE5 Q34880294-D68CFCBC-539A-4B62-BCBF-A9835EAF660A Q35498054-8C471429-5751-4E33-906F-DEB29D5FCC83 Q35836140-2D14D93F-0741-421E-9827-5A747726CAB3 Q35848642-13FF51F7-F60A-4262-8923-9D2A90C53075 Q35928216-9728F2B7-04EF-444E-8F73-F9990C1543D6 Q35989484-195E3C85-693B-4350-B2FD-9458D5BACB17 Q36125714-2ED1FC93-89A5-4174-A7A2-2250AA4BA995 Q36646698-B6CE3F7A-E728-4AC0-BD47-2CB0CEA66F4B Q36754331-4A74857C-CFBD-4CFC-A3A0-BDA809B04918 Q37088207-DE74D55B-60EA-4C4D-B747-DE37778007D3 Q37240218-940052B4-64D6-4762-B1ED-8AF14CB07BF1 Q37254129-2287E9C5-5890-4F73-BA3F-294AB26EF069 Q37522784-FDAE1B5B-A460-4E51-A99E-C86B176E5659 Q37547211-DDE81136-5167-41CD-B95C-049878334FBC Q37628515-1409295C-D313-4F0C-87BE-5B5686479D3F Q37696415-2D458382-BB07-4020-8092-7763D7CD69E3 Q37853197-2B177701-DA34-471F-B4A6-5E2B2F13392A Q37899725-BA2C8EB3-014A-4875-9B9B-1F208123260C Q38059751-DD502332-9909-444B-8363-DEEE7096AC8A Q38072067-CC8DD12C-43ED-44C4-9061-A6DBC3E0354C Q38087785-6301BBE1-FC4C-474B-AEF7-61C7592AE536 Q38218671-6F9635DA-BF41-4B38-BCD3-D94265E6B58B Q38259510-3D798537-A96B-4ADF-8223-3327873EA5D3 Q39447134-DBBF6473-DF59-4B6D-9E94-3BE91989E65E Q39863954-5BB27DE1-5B14-412B-B15E-DC83FD03406B Q40049613-3620E3F3-06CD-46D9-B331-D4831FE2A2FF Q40084746-010FC98C-A509-41B1-BB1D-37E315A2FAC7

P2860

Poly(I:C) is an effective adjuvant for antibody and multi-functional CD4+ T cell responses to Plasmodium falciparum circumsporozoite protein (CSP) and αDEC-CSP in non human primates.

http://www.wikidata.org/entity/Q34416103

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Poly(I:C) is an effective adju ...... DEC-CSP in non human primates.

@ast

Poly(I:C) is an effective adju ...... DEC-CSP in non human primates.

@en

type

label

Poly(I:C) is an effective adju ...... DEC-CSP in non human primates.

@ast

Poly(I:C) is an effective adju ...... DEC-CSP in non human primates.

@en

prefLabel

Poly(I:C) is an effective adju ...... DEC-CSP in non human primates.

@ast

Poly(I:C) is an effective adju ...... DEC-CSP in non human primates.

@en

P1433

Q34416103-9059D702-28F7-4940-9F9A-33F4C6C81847

P1476

Q34416103-367903F5-92FD-4521-B5E2-29BDE39521B0

P2093

Q34416103-0C4E513B-2B8F-4917-BE67-855319841942

Q34416103-1CFAC2A7-2ACC-4931-A511-8EED3EB21EA2

Q34416103-3DDBC7BC-0E53-4A30-A9A9-A9CD4952710D

Q34416103-55DD09B1-B835-4F90-A944-09258E66E932

Q34416103-9B545644-2274-49D7-8B3B-F5236C4869AA

Q34416103-9B967899-D64C-452B-B49E-2B92AD326B4D

Q34416103-B8C14494-3E0C-4890-BC81-AA030697FDF4

Q34416103-BC0C683E-0AA7-4752-826D-9B45344E3BF5

Q34416103-CAF92E99-AE93-4031-8040-8A0938652CE1

Q34416103-F30FC537-38E9-4244-875A-08EE56D21E6B

P2860

Q34416103-0500F0D7-905D-4783-B510-B496EBF2B76A

Q34416103-107A4A50-F60E-4A00-AAAA-62904CC7142D

Q34416103-1141810B-1232-4B31-8BB8-1B5CD7FC7672

Q34416103-1B91C11E-A45B-48CB-9737-A2A9D1D15B9C

Q34416103-239901BE-534B-4694-B136-7AD81638FACD

Q34416103-276B0BAF-E235-4DEA-BD6A-D4CD7BE95DD6

Q34416103-2DB7E930-91D5-4A1C-A764-890FC9364F89

Q34416103-311E62E3-BC6D-4FD3-B43E-70A29FD4761C

Q34416103-31F8A94F-C8C6-4D9F-B367-4C5BE95F27FD

Q34416103-37CFC432-79FF-4A71-931F-6AE7EFE564B6

P304

Q34416103-3382AED3-EE89-4B46-B87E-3F445A026776

P31

Q34416103-FC04E609-E40C-4F56-9DB0-F2E81F07B7E1

P356

Q34416103-0E5EB0AB-4008-4ACD-8145-B591ABF76441

P407

Q34416103-150CA0A2-841B-4884-B04E-458964C23068

P433

Q34416103-7CF28E9E-0AE4-4288-9BE3-D7269D68BC7C

P478

Q34416103-3F58EBAE-8C26-42B6-89E2-52F2DB265989

P50

Q34416103-05B644D7-2EEE-47C1-8B92-61B9790093C9

Q34416103-0BBA6934-6AEE-47B1-9436-10411C4B0838

Q34416103-DA92916E-9DB9-4454-94AB-AA4C6B016733

P577

Q34416103-8288EA1D-1D3F-40B5-85BE-66BDD2A18024

P5875

Q34416103-07535BD1-539D-414F-99CF-CE5703B52852

P698

Q34416103-4F2196F1-2150-4363-9098-24E4720483A9

P921

Q34416103-BACBACC3-4518-4BF1-84BB-0F6946A586F9

Q34416103-F4956DD9-7947-4036-B47C-B25E81C4A124

P932

Q34416103-BDA147A1-F788-4ED3-A6CC-1CAAFFE66B85

P356

J.VACCINE.2010.08.098

P1433

P1476

Poly(I:C) is an effective adju ...... DEC-CSP in non human primates.

@en

P2093

Adriana Ahumada

http://www.w3.org/2001/XMLSchema#string

Andres M Salazar

http://www.w3.org/2001/XMLSchema#string

Barbara J Flynn

http://www.w3.org/2001/XMLSchema#string

Charles A Anderson

http://www.w3.org/2001/XMLSchema#string

Kathrin Kastenmueller

http://www.w3.org/2001/XMLSchema#string

Kavita Tewari

http://www.w3.org/2001/XMLSchema#string

Ralph M Steinman

http://www.w3.org/2001/XMLSchema#string

Robert A Seder

http://www.w3.org/2001/XMLSchema#string

Tibor Keler

http://www.w3.org/2001/XMLSchema#string

Velmurugan Soundarapandian

http://www.w3.org/2001/XMLSchema#string

P2860

Acquired immunity to malaria

Synthetic double-stranded RNAs are adjuvants for the induction of T helper 1 and humoral immune responses to human papillomavirus in rhesus macaques

A monoclonal antibody to the DEC-205 endocytosis receptor on human dendritic cells

Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites

Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei

Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major

Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data.

Evaluation of RTS,S/AS02A and RTS,S/AS01B in adults in a high malaria transmission area.

HIV Gag protein conjugated to a Toll-like receptor 7/8 agonist improves the magnitude and quality of Th1 and CD8+ T cell responses in nonhuman primates.

The basolateral domain of the hepatocyte plasma membrane bears receptors for the circumsporozoite protein of Plasmodium falciparum sporozoites.

P304

7256-7266

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.VACCINE.2010.08.098

http://www.w3.org/2001/XMLSchema#string

P407

P433

45

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Michel C. Nussenzweig

Silvia B Boscardin

Stephen L Hoffman

P577

2010-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46287702

http://www.w3.org/2001/XMLSchema#string

P698

20846528

http://www.w3.org/2001/XMLSchema#string

P921

Plasmodium falciparum

P932

3004225

http://www.w3.org/2001/XMLSchema#string